|
2 Companies |
|
2 Products |
|
2 Products |
|
3 Mechanisms of Action |
|
0 Trials |
|
10 News |
|
- Signifor (pasireotide) / Recordati
Enrollment change, Trial withdrawal: SOM230 Ectopic ACTH-producing Tumors (clinicaltrials.gov) - Jan 26, 2018
P2, N=0, Withdrawn, Sponsor: Cedars-Sinai Medical Center
N=16 --> 0 | Recruiting --> Withdrawn
- | Signifor (pasireotide) / Recordati
New P2 trial: SOM230 Ectopic ACTH-producing Tumors (clinicaltrials.gov) - May 24, 2016
P2, N=16, Recruiting, Sponsor: Cedars-Sinai Medical Center
- |||| Signifor LAR (pasireotide long acting release) / Recordati
Trial completion: Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin (clinicaltrials.gov) - Sep 18, 2015
P2, N=118, Completed, Sponsor: Novartis Pharmaceuticals
N=16 --> 0 | Recruiting --> Withdrawn Active, not recruiting --> Completed
- || Signifor LAR (pasireotide long acting release) / Recordati
Trial primary completion date: Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin (clinicaltrials.gov) - May 26, 2014
P2, N=118, Active, not recruiting, Sponsor: Novartis Pharmaceuticals
Active, not recruiting --> Completed Trial primary completion date: Jan 2014 --> Apr 2015
- || Signifor LAR (pasireotide long acting release) / Recordati
Trial completion date: Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin (clinicaltrials.gov) - May 26, 2014
P2, N=118, Active, not recruiting, Sponsor: Novartis Pharmaceuticals
Trial primary completion date: Jan 2014 --> Apr 2015 Trial completion date: Jan 2014 --> Apr 2015
- Enrollment change: A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia (clinicaltrials.gov) - Feb 23, 2014
P=N/A, N=2, Terminated, Sponsor: Corcept Therapeutics
Trial completion date: Jan 2014 --> Apr 2015 N=150 --> 2
- Korlym (mifepristone) / Corcept Therap
Enrollment change: Compassionate Use of CORLUX (clinicaltrials.gov) - Sep 18, 2013
P3, N=4, Completed, Sponsor: Corcept Therapeutics
N=150 --> 2 N=25 --> 4
- Korlym (mifepristone) / Corcept Therap
Trial completion: Compassionate Use of CORLUX (clinicaltrials.gov) - Sep 18, 2013
P3, N=4, Completed, Sponsor: Corcept Therapeutics
N=25 --> 4 Active, not recruiting --> Completed
- ||| Signifor LAR (pasireotide long acting release) / Recordati
Enrollment closed: Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin (clinicaltrials.gov) - Apr 15, 2013
P2, N=118, Active, not recruiting, Sponsor: Novartis Pharmaceuticals
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- || Korlym (mifepristone) / Corcept Therap
Trial completion: SEISMIC: A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome (clinicaltrials.gov) - Oct 20, 2011
P3, N=50, Completed, Sponsor: Corcept Therapeutics
Recruiting --> Active, not recruiting Active, not recruiting --> Completed